Omnicell OMCL Reportable Segment — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Omnicell in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Omnicell's reportable segment — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Omnicell's reportable segment — total revenues?
- Omnicell (OMCL) reported reportable segment — total revenues of $309.88M in Q1 2026.
- How has Omnicell's reportable segment — total revenues changed year-over-year?
- Omnicell's reportable segment — total revenues increased by 14.9% year-over-year, from $269.67M to $309.88M.
- What is the long-term trend for Omnicell's reportable segment — total revenues?
- Over 3 years (2022 to 2025), Omnicell's reportable segment — total revenues has grown at a -2.9% compound annual growth rate (CAGR), from $1.3B to $1.18B.
- What does reportable segment — total revenues mean?
- This metric represents the total gross income generated by the company's primary reportable business segment from its core operations. It reflects the scale of the segment's market presence and its ability to monetize medication management software and automation solutions. Tracking this figure helps investors assess the segment's growth trajectory and its contribution to the overall enterprise revenue.